-Robert Radinsky Researcher Activity Profile

Research Author Detailed Information 

Robert Radinsky Publication Rate By Year

Robert Radinsky has published 1 paper(s) in 2006, 3 paper(s) in 2007, 2 paper(s) in 2008, for a total of 6 research publications in total.

Robert R Radinsky Author Information

LAST NAME: radinsky

FIRST NAME: robert

INITIALS: R

AFFILIATION:

Papers

Robert Radinsky's Publication Record

1. AMG 706, an oral, multikinase inhibitor that selectively targets vascular endothelial growth factor, platelet-derived growth factor, and kit receptors, potently inhibits angiogenesis and induces regression in tumor xenografts. Year Published: 2006
Department of Oncology Research, Amgen, Inc., Thousand Oaks, CA 91320-1799, USA. tonyp@amgen.com
2. AMG 102, A Fully Human Anti-Hepatocyte Growth Factor/Scatter Factor Neutralizing Antibody, Enhances the Efficacy of Temozolomide or Docetaxel in U-87 MG Cells and Xenografts. Year Published: 2007
Authors' Affiliation: Department of Oncology Research, Amgen, Inc., Thousand Oaks, California.
3. AMG 102, a fully human anti-hepatocyte growth factor/scatter factor neutralizing antibody, enhances the efficacy of temozolomide or docetaxel in U-87 MG cells and xenografts. Year Published: 2007
Department of Oncology Research, Amgen Inc., One Amgen Center Drive, Thousand Oaks, CA 91362, USA. tjun@amgen.com
4. AMG 102, a fully human anti-hepatocyte growth factor/scatter factor neutralizing antibody, enhances the efficacy of temozolomide or docetaxel in U-87 MG cells and xenografts. Year Published: 2007
Department of Oncology Research, Amgen Inc., One Amgen Center Drive, Thousand Oaks, CA 91362, USA. tjun@amgen.com
5. Wild-Type KRAS Is Required for Panitumumab Efficacy in Patients With Metastatic Colorectal Cancer. Year Published: 2008
Corresponding author: Rafael G. Amado, Amgen, Inc, One Amgen Center Dr, MS 38-2-B, Thousand Oaks, CA 91320-1799; e-mail: ramado@amgen.com.
6. Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer. Year Published: 2008
Amgen, Inc, One Amgen Center Dr, MS 38-2-B, Thousand Oaks, CA 91320-1799, USA. ramado@amgen.com